Literature DB >> 28989412

Epidemiology and outcomes of Stenotrophomonas maltophilia and Burkholderia cepacia infections among trauma patients of India: a five year experience.

Nonika Rajkumari1, Purva Mathur2, Amit K Gupta3, Kumkum Sharma3, Mahesh C Misra4.   

Abstract

BACKGROUND: Infections by uncommon non-fermenting Gram negative bacteria are on the rise, but little is known about the risk factors and drug resistance in trauma patients in India. This study explored the infections caused by Stenotrophomonas maltophilia and/or Burkholderia cepacia in trauma patients over a period of 5 years.
MATERIAL AND METHODS: Patients admitted for trauma care with S. maltophilia and/or B. cepacia isolated from clinical specimens were enrolled. Characteristics regarding the strain isolation, drug sensitivity pattern, multidrug resistance (MDR), patient, outcomes, and differentiation of true infection from colonisation were observed.
RESULTS: Of the total 233 isolates, 102 were S. maltophilia and 131 were B. cepacia; 4.3% were responsible for polymicrobial infections with other bacteria. There were more B. cepacia MDR isolates than S. maltophilia. Maximum resistance was found to tetracycline (86.7%) and tobramycin (86.7%) in B. cepacia and to co-trimoxazole (68.7%) in S. maltophilia. Of these, 21 (16.03%) had a fatal outcome and the remaining 111 (84.7%) were discharged healthy. The in-hospital mortality rate associated with B. cepacia was much (16%) higher than S. maltophilia (13%) at this centre.
CONCLUSION: The analysis of epidemiology and outcome of these infections will help to inform their management and treatment.

Entities:  

Keywords:  Bacteria; epidemology; infection; infection prevention and control; surveillance

Year:  2014        PMID: 28989412      PMCID: PMC5074113          DOI: 10.1177/1757177414558437

Source DB:  PubMed          Journal:  J Infect Prev        ISSN: 1757-1782


  14 in total

1.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

Review 2.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

3.  Causative pathogen dictates optimal duration of antimicrobial therapy for ventilator-associated pneumonia in trauma patients.

Authors:  Louis J Magnotti; Martin A Croce; Ben L Zarzaur; Joseph M Swanson; G Christopher Wood; Jordan A Weinberg; Timothy C Fabian
Journal:  J Am Coll Surg       Date:  2011-04       Impact factor: 6.113

4.  Evaluation of a clinical pathway for ventilator-associated pneumonia: changes in bacterial flora and the adequacy of empiric antibiotics over a three-year period.

Authors:  G Christopher Wood; Eric W Mueller; Martin A Croce; Bradley A Boucher; Scott D Hanes; Timothy C Fabian
Journal:  Surg Infect (Larchmt)       Date:  2005       Impact factor: 2.150

5.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

6.  PCR ribotyping and endonuclease subtyping in the epidemiology of Burkholderia cepacia infection.

Authors:  M R Shreve; S J Johnson; C E Milla; C L Wielinski; W E Regelmann
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

7.  Bacteraemia in adults due to glucose non-fermentative Gram-negative bacilli other than P. aeruginosa.

Authors:  F Vidal; J Mensa; M Almela; M Olona; J A Martínez; F Marco; M J López; A Soriano; J P Horcajada; J M Gatell; C Richart
Journal:  QJM       Date:  2003-03

8.  Nosocomial outbreak of Pseudomonas cepacia respiratory infection in immunocompromised patients associated with contaminated nebulizer devices.

Authors:  K Takigawa; J Fujita; K Negayama; Y Yamagishi; Y Yamaji; K Ouchi; K Yamada; M Abe; T Nakazawa; K Kawanishi
Journal:  Kansenshogaku Zasshi       Date:  1993-11

9.  Soft tissue infection caused by Burkholderia cepacia in a child with polyarteritis nodosa.

Authors:  Başak Yıldız; Muhterem Duyu; Betül Sözeri; Bülent Karapınar
Journal:  Turk J Pediatr       Date:  2012 Nov-Dec       Impact factor: 0.552

10.  Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.

Authors:  Yu Lin Wang; Marco R Scipione; Yanina Dubrovskaya; John Papadopoulos
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

View more
  4 in total

1.  A prospective study of microbiological characterization and clinical facets of Stenotrophomonas maltophilia infections.

Authors:  Suvayu Biswas; Anupam Berwal; Kiran Chawla
Journal:  Iran J Microbiol       Date:  2020-08

2.  Prevalence and Antibiotic Resistance of Stenotrophomonas maltophilia in Respiratory Tract Samples: A 10-Year Epidemiological Snapshot.

Authors:  Márió Gajdács; Edit Urbán
Journal:  Health Serv Res Manag Epidemiol       Date:  2019-08-15

3.  Resistance Levels and Epidemiology of Non-Fermenting Gram-Negative Bacteria in Urinary Tract Infections of Inpatients and Outpatients (RENFUTI): A 10-Year Epidemiological Snapshot.

Authors:  Márió Gajdács; Katalin Burián; Gabriella Terhes
Journal:  Antibiotics (Basel)       Date:  2019-09-09

4.  Antimicrobial susceptibility pattern of Burkholderia cepacia complex & Stenotrophomonas maltophilia from North India: Trend over a decade (2007-2016).

Authors:  Shveta Sethi; Megha Sharma; Sunil Kumar; Lipika Singhal; Vikas Gautam; Pallab Ray
Journal:  Indian J Med Res       Date:  2020-12       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.